MRI Can Be Used To Assess Cervical Neuroendocrine Carcinoma

Diagnostic Imaging (2/2, Palmer) reports a new study suggests MRI can be used to identify and accurately assess neuroendocrine carcinoma (NEC) in the uterine cervix. Researchers in Japan “enrolled 62 women, ranging from ages 26 to 82, who had histologically surgery-proven uterine cervical NEC, and examined them with T2-weighted MRI,” determining that “among the 50 women in the group who underwent radical hysterectomy and lymphadenectomy without neoadjuvant chemotherapy, MRI was able to provide intra-pelvic T staging with 88-percent overall accuracy for pathology staging.” The findings were published in Oncotarget.